OBESITY: What Is It, Who Has It, and Why Do We Get it?
Sunday, May 10, 2020
8:00 AM – 8:30 AM
Participants should be aware of the following financial/non-financial relationships: Michael A. Bush, MD, FACE: AstraZeneca () : Honorarium; Boehringer Ingleheim () : Honorarium; Eli Lilly () : Honorarium; Janssen () : Honorarium; Novo Nordisk () : Honorarium; Sanofi () : Honorarium
State one environmental and one genetic factor important in the development of obesity
Classify the different stages of obesity
Define the ABCD terminology for obesity preferred by AACE and many other societies